[1]沈海洋,杨光,刘瑞宝,等.肝右叶前、后段原发性肝癌动脉化疗栓塞术后近期疗效比较[J].介入放射学杂志,2010,(05):382.
　SHEN Haiyang,YANG Guang,LIU Ruibao,et al.Short－term effects of TACE for primary hepatocellular carcinoma of the right hepatic lobe：a comparison between the lesions in anterior segments and the lesions in posterior segments[J].journal interventional radiology,2010,(05):382.
点击复制

肝右叶前、后段原发性肝癌动脉化疗栓塞术后近期疗效比较()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2010年05期
页码:
382
栏目:
肿瘤介入
出版日期:
2010-05-15

文章信息/Info

Title:
Short－term effects of TACE for primary hepatocellular carcinoma of the right hepatic lobe：a comparison between the lesions in anterior segments and the lesions in posterior segments
作者:
沈海洋; 杨光; 刘瑞宝; 等
１５００８１哈尔滨医科大学附属肿瘤医院介入科
Author(s):
SHEN Hai－yang; YANG Guang; LIU Rui－bao; HE Dong－feng; YANG Yi ; SUN Hou－bin; WANG Hui－wen
，Affiliated Tumor Hospital of Haerbin Medical University，Haerbin１５００８１，China
关键词:
肝细胞癌; 经导管动脉化疗栓塞; 肝段; 近期疗效
分类号:
R７３５.７
摘要:
目的分析位于肝右叶前、后段原发性肝癌（HCC）患者在TACE治疗后病灶近期疗效的差异及意义。方法回顾性分析我院２００８年３月－２００９年１月首次行肝动脉化疗栓塞术（TACE）治疗２８３例HCC患者，将其中按影像学检查符合筛选标准５８例（８３个病灶）分两组。A组：共２３例，病灶位于肝右叶前段（Ⅴ、Ⅷ段）；B组：共３５例，病灶位于肝右后段（Ⅵ、Ⅶ段）。分析经TACE治疗前１周内及治疗后１、３个月复查的CT、MRI 资料，按照RECIST标准比较两组病灶近期疗效的差异。结果治疗１个月后A、B两组的CR、PR、SD、PD分别为０、４．３％、８７．０％、８．７％和０、２２．９％、６８．６％、８．６％，有效率OR（CR＋PR）比较差异无统计学意义（P＝０．０７３）；３个月后两组的CR、PR、SD、PD分别为０、８．７％、７３．９％、１７．４％和０、３４．３％、６２．９％、２．９％，OR比较差异有统计学意义（P＝０．０３１）；两组病灶大小随时间变化，后段组比前段组缩小明显（F＝７．８７３，P＜０．０５）。结论肝右叶后段HCC经TACE治疗后短期疗效优于前段，对于不同位置病灶的综合治疗有重要指导价值。

参考文献/References:

［１］Cabibbo G，Latteri F，Antonucci M，et al．Multimodal approaches to the treatment of hepatocellular carcinoma ［J］．Nat Clin Pract Gastroenterol Hepatol，２００９，６：１５９－１６９．
［２］Mendizabal M，Reddy KR．Current management of hepatocellular carcinoma ［J］．Med Clin North Am，２００９，９３：８８５－９００．
［３］王建华．呼唤规范化的肝癌介入治疗［J］．介入放射学杂志，２００７，１６：１４５－１４７．
［４］刘瑞宝，杨光，崔亚利，等． １２５ I粒子植入联合动脉灌注化疗治疗不可切除性肺癌［J］．介入放射学杂志，２００９，１８：４５３－４５６．
［５］单鸿，姜在波，马壮．临床血管解剖学：介入放射学动脉图谱［M］．广州：广东世界图书出版公司，２００１：１７８－１８０．
［６］刘嵘，王建华，周康荣，等．碘油栓塞后临床长期稳定肝癌病灶的MRI 研究［J］．放射学实践，２００６，０９：９２８－９３２．
［７］程红岩．肝动脉插管治疗中复杂血管的分类和处理［J］．介入放射学杂志，２００９，１８：７１７－７２０．
［８］王伟昱，吕维富，侯昌龙，等．原发性肝癌肝外血供的血管造影分析及介入治疗［J］．介入放射学杂志，２００７，０８：５３８－５４０．
［９］Chung JW，Kim HC，Yoon JH，et al．Transcatheter arterial chemoembolization of hepatocellular carcinoma ：prevalence and causative factors of extrahepatic collateral arteries in４７９patients［J］．Korean J Radiol，２００６，７：２５７－２６６．
［１０］Yamagami T，Kato T，Tanaka O，et al．Influence of extrahepatic arterial inflow into the posterior segment or caudate lobe of the liver on repeated hepatic arterial infusion chemotherapy［J］．J Vasc Interv Radiol，２００５，１６：４５７－４６３．
［１１］李秋洋，周晓东，于铭，等．高强度聚焦超声对兔肝肿瘤微血管密度及血管内皮细胞生长因子的影响［J］．中华超声影像学杂志，２００９，１８：７１－７４．
［１２］郑云峰，陈克敏，王忠敏，等．CT引导下经皮射频消融治疗较大原发性肝癌的临床应用［J］．介入放射学杂志，２００９，１８：３５３－３５６．
［１３］周怡婷，曹建民，许健，等．氩氦刀联合栓塞化疗治疗中晚期肝癌的临床研究［J］．介入放射学杂志，２００９，１８：７３３－７３６．
［１４］陆骊工，胡宝山，李勇，等．高频热消融联合TACE治疗中晚期原发性肝癌的疗效观察［J］．中华医学杂志，２００８，２３：１６１８－１６２０．

相似文献/References:

[1]官泳松,贺庆.肝癌介入治疗中应用p５３的几个要点[J].介入放射学杂志,2008,(11):761.
　GUAN Yongsong,HE Qing.Essentials in clinical application of p５３for tumors intervention－example of liver cancer[J].journal interventional radiology,2008,(05):761.
[2]郭丽萍,张晓玲,王莉娜.经导管肝动脉化疗栓塞联合高强度聚焦超声治疗原发性肝癌的护理[J].介入放射学杂志,2010,(04):328.
　GUO Liping,ZHANG Xiaoling,WANG Lina.The nursing care for patients of hepatocellular carcinoma treated with transcatheter hepatic arterial chemoembolization and high intensive focus ultrasound[J].journal interventional radiology,2010,(05):328.
[3]池嘉昌,沈加林,许建荣,等.全肝CT灌注成像在原发性肝癌TACE术后局部病灶活性评估中的临床应用[J].介入放射学杂志,2010,(07):540.
　CHI Jiachang,SHEN Jialin,XU Jianrong,et al.Clinical application of whole－liver perfusion－enhanced CT imaging in evaluating the activity of residual hepatocellular carcinoma after TACE[J].journal interventional radiology,2010,(05):540.
[4]翁志成,杨维竹,江娜,等.CT引导下１２５I放射性粒子植入治疗肝癌门静脉癌栓的疗效评价[J].介入放射学杂志,2010,(07):535.
　WENG Zhicheng,YANG Weizhu,JIANG Na,et al.Evaluation of CT－guided１２５I seed implantation combined with transcatheter arterial chemoem－bolization in treating portal vein tumor thrombus associated with hepatocellular carcinoma[J].journal interventional radiology,2010,(05):535.
[5]王悍 王精兵 张贵祥 王麟川.肝细胞癌动脉化疗栓塞术后并发脑梗死一例[J].介入放射学杂志,2005,(04):442.
　WANG Han WANG Jing-bing ZHANG Gui-xiang WANG Lin-chuan.Cerebral infarction aften transaterial shemoembolization for hepatocellular carcinoma a cage report[J].journal interventional radiology,2005,(05):442.
[6]张绪敬,程佩芳,董光,等.原发性肝癌经导管化疗、栓塞前后血中凝血酶原变化的研究[J].介入放射学杂志,1992,(01):33.
[7]欧阳墉,马和平,张学军,等.肝细胞癌的鉴别诊断——附10例分析[J].介入放射学杂志,1996,(01):40.
[8]周斌,李征然,钱结胜,等.原发性肝癌肝移植后肿瘤复发的化疗栓塞治疗[J].介入放射学杂志,2009,(03):185.
　ZHOU Bin,LI Zhengran,QIAN Jiesheng,et al.Chemoembolization for recurrent hepatocellular carcinoma after liver transplantation[J].journal interventional radiology,2009,(05):185.
[9]黄渊全,贾中芝,冯耀良,等.CT灌注成像在肝癌TACE术后疗效评价中的应用价值[J].介入放射学杂志,2009,(06):437.
　HUANG Yuan-quan,JIA Zhong-zhi,FENG Yao-liang,et al.Clinical application of CT perfusion imaging in estimating the efficacy of transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma[J].journal interventional radiology,2009,(05):437.
[10]王惠文,刘瑞宝,刘　　　岩,等.原发性肝癌ＴＡＣＥ后ＦＡＫ、ＮＦκＢｐ６５表达及意义[J].介入放射学杂志,2011,(08):621.
　WANG Hui-wen,LIU Rui-bao,LIU Yan,et al.The expression and significance of FAK and NF-κBp65 in hepatocellular carcinoma after transcatheter arterial chemoembolization[J].journal interventional radiology,2011,(05):621.
[11]顾萃华,潘仕文,邱 珏,等.基于MRI的放射组学模型预测中晚期肝癌患者TACE后肿瘤反应[J].介入放射学杂志,2024,33(01):63.
　GU Cuihua,PAN Shiwen,QIU Jue,et al.Application of MRI-based radiomics model in predicting the tumor response in patients with advanced hepatocellular carcinoma after transcatheter arterial chemoembolization[J].journal interventional radiology,2024,33(05):63.

备注/Memo

备注/Memo:
收稿日期：２００９－１１－０２
更新日期/Last Update: 2010-05-15